Nursing Home Admission and Initiation of Domiciliary Care After Ischemic Stroke - The Importance of Time to Thrombolysis.
Aged
Aged, 80 and over
Databases, Factual
Denmark
/ epidemiology
Female
Fibrinolytic Agents
/ administration & dosage
Home Care Services
Humans
Infusions, Intravenous
Ischemic Stroke
/ diagnosis
Male
Middle Aged
Nursing Homes
Patient Admission
Patient Discharge
Registries
Risk Assessment
Risk Factors
Thrombolytic Therapy
/ adverse effects
Time Factors
Time-to-Treatment
Treatment Outcome
Epidemiology
Nursing home
Stroke
Thrombolytic therapy
Journal
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
02
01
2021
revised:
16
05
2021
accepted:
23
05
2021
pubmed:
19
6
2021
medline:
27
7
2021
entrez:
18
6
2021
Statut:
ppublish
Résumé
There is a paucity of data on the risk of nursing home admission or domiciliary care initiation according to time to intravenous thrombolysis for ischemic stroke. We investigated the association between time to intravenous thrombolysis and the composite of nursing home admission or domiciliary care initiation in patients with acute ischemic stroke. In this nationwide cohort study, all stroke patients treated with intravenous thrombolysis (2011-2015) and alive at discharge were identified from the Danish Stroke Registry and other nationwide registries. The composite of nursing home admission or domiciliary care initiation one year post-discharge according to time to thrombolysis was examined with multivariable Cox regression. The study population comprised 4,349 patients (median age 67 years [25 In patients admitted with ischemic stroke, increasing time to thrombolysis was associated with a greater risk of the composite of nursing home admission or domiciliary care initiation. Continued efforts to shorten the time delay from symptom-onset to initiation of thrombolysis are warranted.
Identifiants
pubmed: 34144336
pii: S1052-3057(21)00319-0
doi: 10.1016/j.jstrokecerebrovasdis.2021.105916
pii:
doi:
Substances chimiques
Fibrinolytic Agents
0
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
105916Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None.